Research Article
[Retracted] Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease
Table 3
Comparison of coagulation levels between the 2 groups (
).
| Group | Cases () | DD (mg/L) | ATIII (%) | PC (mg/L) | hs-CRP (mg/L) | Pretreatment | Posttreatment | Pretreatment | Posttreatment | Pretreatment | Posttreatment | Pretreatment | Posttreatment |
| Control group | 55 | | | | | | | | | Study group | 55 | | | | | | | | | | | 0.344 | 12.890 | 0.465 | 10.900 | 2.619 | 9.065 | 2.490 | 9.445 | | | 0.731 | | 0.643 | | | | | |
|
|